New: Introducing the Finviz Crypto Map

Learn More
Last Close
Jul 17 02:45PM ET
1.88
Dollar change
+0.06
Percentage change
3.30
%
Index- P/E- EPS (ttm)- Insider Own3.35% Shs Outstand3.81M Perf Week-6.00%
Market Cap7.17M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float3.69M Perf Month16.05%
Enterprise Value- PEG- EPS next Q- Inst Own6.13% Short Float1.72% Perf Quarter-43.71%
Income- P/S- EPS this Y- Inst Trans0.11% Short Ratio0.32 Perf Half Y-64.46%
Sales- P/B- EPS next Y- ROA- Short Interest0.06M Perf YTD-56.48%
Book/sh- P/C- EPS next 5Y- ROE- 52W High19.00 -90.11% Perf Year-89.12%
Cash/sh- P/FCF- EPS past 3/5Y29.88% -52.02% ROIC- 52W Low1.34 40.50% Perf 3Y-99.57%
Dividend Est.- EV/EBITDA- Sales past 3/5Y15.69% 16.01% Gross Margin- Volatility14.84% 10.10% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM11.95% Oper. Margin- ATR (14)0.18 Perf 10Y-
Dividend Ex-Date- Quick Ratio- Sales Y/Y TTM- Profit Margin- RSI (14)54.16 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio- EPS Q/Q-1121.45% SMA2018.09% Beta0.22 Target Price14.00
Payout- Debt/Eq- Sales Q/Q- SMA50-2.02% Rel Volume0.43 Prev Close1.82
Employees26 LT Debt/Eq- EarningsApr 01 BMO SMA200-64.89% Avg Volume200.80K Price1.88
IPONov 05, 2021 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume70,340 Change3.30%
Date Action Analyst Rating Change Price Target Change
Feb-14-25Initiated Maxim Group Buy $14
Nov-25-24Downgrade H.C. Wainwright Buy → Neutral
Nov-21-23Downgrade Cantor Fitzgerald Overweight → Neutral
Jun-21-22Initiated H.C. Wainwright Buy $25
Jul-15-25 08:01AM
Jun-25-25 08:01AM
Jun-11-25 06:42AM
Jun-10-25 09:01AM
May-21-25 06:00AM
08:01PM Loading…
May-19-25 08:01PM
May-16-25 08:01AM
Apr-29-25 08:01AM
Apr-28-25 08:01AM
Apr-01-25 08:01AM
Mar-28-25 06:49AM
Mar-27-25 09:01AM
Mar-20-25 10:35AM
Mar-19-25 05:35PM
Mar-13-25 08:01AM
08:01AM Loading…
Mar-03-25 08:01AM
Feb-20-25 08:01AM
Feb-11-25 08:01AM
Jan-27-25 08:01AM
Jan-21-25 08:01AM
Dec-20-24 10:31AM
Dec-19-24 08:01AM
Dec-16-24 05:00PM
Dec-12-24 08:00PM
Nov-29-24 08:45AM
Nov-13-24 07:23PM
Nov-12-24 09:00AM
Oct-22-24 08:10AM
Oct-21-24 08:01AM
Oct-10-24 05:37PM
08:01AM Loading…
Oct-08-24 08:01AM
Oct-01-24 02:11PM
08:01AM
Sep-20-24 10:48AM
Sep-18-24 08:01AM
Sep-04-24 04:01AM
Jul-30-24 12:09PM
Jul-25-24 08:01AM
Jul-19-24 12:38PM
Jul-10-24 04:12AM
Jul-09-24 07:39AM
03:01AM
Jul-02-24 01:38PM
08:01AM
Jun-04-24 01:45PM
Jun-03-24 08:01AM
May-31-24 05:01PM
May-29-24 07:39AM
May-28-24 08:01AM
May-20-24 08:01AM
May-17-24 07:23AM
May-16-24 10:51AM
May-07-24 08:01AM
Apr-29-24 12:02PM
Apr-25-24 09:29AM
Apr-10-24 12:47PM
Apr-09-24 09:53PM
08:01AM
Mar-19-24 08:01AM
Mar-18-24 08:01AM
Mar-12-24 08:01AM
Mar-08-24 12:00PM
Mar-05-24 08:01AM
Feb-28-24 12:54PM
Feb-27-24 08:01AM
Feb-22-24 02:21PM
08:01AM
Feb-21-24 08:01AM
Feb-07-24 12:13PM
Feb-06-24 08:01AM
Feb-01-24 04:17PM
Jan-11-24 08:01AM
Jan-09-24 03:40PM
08:01AM
Dec-29-23 02:48PM
Dec-19-23 08:01AM
Dec-12-23 08:01AM
Dec-05-23 02:06PM
09:01AM
Nov-29-23 08:01AM
Nov-20-23 08:01AM
Nov-16-23 08:01AM
Nov-15-23 09:01AM
Nov-13-23 09:00AM
Nov-09-23 08:01AM
Nov-07-23 08:01AM
Nov-01-23 08:40AM
Oct-31-23 08:01AM
Oct-26-23 08:01AM
Oct-18-23 08:01AM
Oct-17-23 03:16PM
Oct-11-23 08:01AM
Oct-10-23 03:53PM
Oct-05-23 08:01AM
Oct-04-23 02:10PM
08:01AM
Sep-27-23 01:43PM
08:01AM
Sep-22-23 02:51PM
Sep-20-23 03:01AM
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.